PRETAGOSTINI, Renzo
 Distribuzione geografica
Continente #
NA - Nord America 6.219
EU - Europa 2.039
AS - Asia 1.279
AF - Africa 165
SA - Sud America 59
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.768
Nazione #
US - Stati Uniti d'America 6.137
IT - Italia 632
SG - Singapore 556
IN - India 389
SE - Svezia 380
UA - Ucraina 307
CN - Cina 280
FI - Finlandia 268
DE - Germania 152
ZA - Sudafrica 108
BG - Bulgaria 90
CA - Canada 71
AR - Argentina 57
TG - Togo 49
GB - Regno Unito 47
IE - Irlanda 44
RU - Federazione Russa 40
IR - Iran 27
RO - Romania 13
BE - Belgio 11
AT - Austria 9
NL - Olanda 9
FR - Francia 8
ID - Indonesia 8
MX - Messico 8
CH - Svizzera 7
BJ - Benin 5
ES - Italia 5
TR - Turchia 4
AU - Australia 3
BZ - Belize 3
GR - Grecia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PL - Polonia 3
TW - Taiwan 3
AZ - Azerbaigian 2
DK - Danimarca 2
JP - Giappone 2
LT - Lituania 2
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
KR - Corea 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 9.768
Città #
Fairfield 849
Chandler 538
Woodbridge 498
Ashburn 408
Singapore 386
Seattle 320
Houston 318
Cambridge 279
Wilmington 278
Ann Arbor 268
Princeton 268
Plano 205
Rome 196
Santa Clara 164
Dearborn 144
Beijing 131
Jacksonville 124
Johannesburg 104
Boston 98
Millbury 97
Lawrence 90
Sofia 90
San Paolo di Civitate 86
San Diego 80
Helsinki 73
Andover 66
Bremen 53
Federal 53
Lomé 49
Dublin 44
Des Moines 38
Boardman 35
Ottawa 35
Norwalk 34
Toronto 31
Grafing 26
Milan 24
Falls Church 22
Moscow 22
New York 19
Kunming 18
Los Angeles 16
Nanjing 16
Bühl 15
Hefei 15
Zanjan 15
Mannheim 12
Brussels 11
San Mateo 11
Dallas 10
London 10
Buffalo 9
Frankfurt am Main 9
Jinan 9
Leawood 9
Jakarta 8
San Jose 8
Bologna 7
Guangzhou 7
Mexico City 7
Regensburg 7
Vienna 7
Arzergrande 6
Falkenstein 6
Indiana 6
Laurel 6
Nanchang 6
Redmond 6
Shanghai 6
Fasano 5
Pescara 5
Sacramento 5
Washington 5
Wuhan 5
Azzano San Paolo 4
Buenos Aires 4
Chengdu 4
Fremont 4
Henderson 4
Istanbul 4
Panicale 4
Pisa 4
Southend 4
Atlanta 3
Auburn Hills 3
Auckland 3
Augusta 3
Basiano 3
Belize City 3
Bern 3
Fucecchio 3
Jerzu 3
Jian 3
Kumanovo 3
Montréal 3
Mumbai 3
Pontinia 3
Rieti 3
Shenyang 3
Torino 3
Totale 7.033
Nome #
CELSIOR: UNA NUOVA SOLUZIONE EXTRACELLULARE PER LA PERFUSIONE E LA CONSERVAZIONE IPOTERMICA DEGLI ORGANI SOTTODIAFRAMMATICI. ESPERIENZA PERSONALE 249
Delayed introduction of everolimus in de novo renal transplanted patients. A single-center experience 124
Automated intelligent microscopy for the recognition of decoy cells in urine samples of kidney transplant patients 108
Viremia negativization after BK virus infection in kidney transplantation. A national bicentric study 99
Delayed Graft Function Decreases Early and Intermediate Graft Outcomes After Expanded Criteria Donor Kidney Transplants 94
Plasmapheresis, photopheresis, and endovenous immunoglobulin in acute antibody-mediated rejection in kidney transplantation 94
Risk Management Systems for Health Care and Safety Development on Transplantation: A Review and a Proposal 93
Clinical Results of Treatment of Postsurgical Endotoxin-Mediated Sepsis With Polymyxin-B Direct Hemoperfusion 91
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 89
Multiple organ failure associated with Coxsackie virus in a kidney transplant patient. Case report 88
Early Urine Output Predicts Graft Survival After Kidney Transplantation 87
Adacolumn Treatment in Kidney Transplant Patients With Hepatitis C Virus 87
EFFICIENCY OF TRANSGENESIS USING SPERM-MEDIATED GENE TRANSFER :GENERATION OF hDAF TRANSGENIC PIGS 82
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 82
Perfusion time anuria and nephrotoxicity in cadaveric renal transplant. 81
Allospecific human T suppressor cells in kidney transplantation. 81
Color Doppler ultrasound in renal transplant: Role of resistive index versus renal cortical ratio in the evaluation of renal transplant diseases 81
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS 81
Survival after kidney transplantation does not differ with 50-59- or over 60-year-old expanded-criteria donors. 80
One hundred sixteen cases of acute liver failure treated with MARS 78
MOFETIL MYCOPHENOLATE IN RENAL TRANSPLANTATION 77
Evaluation of suitability of kidney for transplant. Histomorphometric analysis 77
Alloantibodies and outcomes of deceased donor kidney allografts 75
A case of portal vein arterialization after a liver transplant 75
Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation 75
Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. 74
IMMUNOSUPPRESSIVE THERAPY IN HIGH RISK PATIENTS 73
The organizational model of the Interregional Transplant Agency Organizzazione Centro-Sud Trapianti 73
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS 72
A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. 72
Pre-emptive therapy for the treatment of cytomegalovirus after kidney transplantation 72
Surgical technique notes of arterial vascular reconstruction during kidney transplantation: personal experience and literature review 72
Organizzazione Centro-Sud Trapianti: Outcome analysis 1999 to 2002 71
Torque teno virus (TTV): A gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients 70
ANALYSIS OF 160 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS: 1983-1997. 70
Intractable pruritus in patients with hepatitis C virus 69
Liver transplantation: expanding the donor pool 69
Exchange of organs and patients with foreign nations during the first 15 months of activity of the Italian gate to Europe 68
KIDNEY TRANSPLANTATION FROM LIVING DONORS WITH MULTIPLE RENAL ARTERIES. EXPERIENCES WITH FIBRIN SEALING 68
Transplantation activity in the Organizzazione Centro-Sud Trapianti: A retrospective study from 1999 to March 2004 67
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS : 8 YEARS GRAFT AND PATIENT SURVIVAL 67
Opsonic activity of intravenous immunoglobulins used for prophylaxis of infections in transplanted recipients 66
Simultaneous Pancreas-Kidney Transplantation: A Single-Center Experience and Prospective Analysis. 66
RENAL TRANSPLANTATION FROM LIVING UNRELATED VS. RELATED KIDNEY DONORS 65
SURVIVAL IN KIDNEY TRANSPLANTATION FROM LIVING DONORS: A SINGLE CENTER EXPERIENCE 64
Effect of HLA compatibility, pregnancies, blood transfusions, and taboo mismatches in living unrelated kidney transplantation 63
Tacrolimus Trough Levels and Level-to-Dose Ratio in Stable Renal Transplant Patients Converted to a Once-Daily Regimen 63
CONVERSION FROM CYCLOSPORIN TO TACROLIMUS IN CRHONIC ALLOGRAFT NEPHROPATY 62
CLINICAL EXPERIENCE WITH CYCLOSPORIN AT THE ROME UNIVERSITY HOSPITAL. 62
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS: 8 YEARS GRAFT AND PATIENT ACTUARIAL SURVIVAL 61
UNUSUAL CORRELATION OF LATE IGA-NEPHROPATHY RECURRENCE AND RENAL PAPILLARY CARCINOMA DEVELOPED IN A KIDNEY TRANSPLANT RECIPIENT 61
EVOLUZIONE DELL'IMMUNOSOPPRESSIONE NEL TRAPIANTO CLINICO DI RENE:ESPERIENZA SU 700 CASI 60
Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003-2005 period. 60
Predictive Characteristics of Delayed Graft Function After Expanded and Standard Criteria Donor Kidney Transplantations 60
Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells 60
Renal papillary carcinoma developed in a kidney transplant recipient with late IgA-nephropathy 59
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS 59
APHERESIS IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS OF NATIVE AND TRANSPLANTED KIDNEYS: A THERAPEUTIC PROTOCOL. 59
Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival 58
ORGAN ALLOGRAFT RECIPIENTS DEVELOP HLA CLASS I-SPECIFIC T SUPPRESSOR CELLS 58
Diagnostic value of presepsin for bacterial infection in cirrhosis: a pilot study 58
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure 57
Pediatric renal transplantation: anesthesia and perioperative complications 57
Reduction of immunosoppressive therapy in kidney and liver transplant patients with T suppressor cells activity 56
Quality evaluation of solid organ transplant in Italy for the period 2000 to 2002 data from the National Transplant Center 56
Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. 56
LA RICOSTRUZIONE ARTERIOSA NEL TRAPIANTO DI FEGATO:NOTE DI TECNICA CHIRURGICA 56
Monocyte cytotoxic activity in kidney transplant patients 55
Preharvest Donor Arterial Hyperoxia Protects From Initial Poor Graft Function After Liver Transplantation By Increasing Total Protein Liver Concentration 54
Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis 54
[Pulmonary aspergillosis in patients having undergone a kidney transplant]. 54
Kidney diseases 53
LIVING UNRELATED KIDNEY TRANSPLANTATION DONOR: A VALID AND SAFE SOURCE 53
ORGAN ALLOGRAFT RECIPIENTS DEVELOP HLA-CLASS I SPECIFIC T SUPPRESSOR CELLS 53
Pediatric renal transplantation: Personal experience 53
ALPHA-INTERFERON THERAPY IN PATIENTS WITH HEPATITIS INFECTION UNDERGOING ORGAN-TRANSPLANTATION 52
Optimization of Mars Treatments in Patients With Aochf 52
null 52
null 51
SARS-CoV-2 vaccination with bnt162b2 in renal transplant patients. Risk factors for impaired response and immunological implications 51
The use of neoplastic donors to increase the donor pool 50
Alpha Interferon Therapy in patients with virus hepatitis infection undergoing organ transplantation. 50
Multimodal Therapy with Combined Plasmapheresis, Photoapheresis, and Intravenous Immunoglobulin for Acute Antibody-Mediated Renal Transplant Rejection: A 2-Year Follow-up 50
Optimization of the Length of Individual Mars Treatment in Patients With Aochf 49
Living organ donation, a therapeutic possibility, is still poorly used in Italy: a national analysis. 48
Strategies to increase heart transplantation in centre-sud transplant organization. 48
Aspiration cytology as a clinical tool for the diagnosis of Cyclosporine induced nephrotoxicity. 48
Contrast enhanced ultrasound compared with MRI and CT in the evaluation of post-renal transplant complications 47
BENCH SURGERY FOR MULTIPLE RENAL ARTERIES IN KIDNEY TRANSPLANTATION FROM LIVING DONOR 47
LONG-TERM RESULTS IN RECIPIENTS OF MISMATCHED RELATED AND UNRELATED LIVING KIDNEYS IN THE CYCLOSPORIN AGE 47
Expected and observed glomerular filtration rates in kidney transplant patients converted to once daily tacrolimus: 10 years of follow-up 47
ASPETTI ETICI DEL TRAPIANTO DI RENE DA DONATORE VIVENTE 46
Tacrolimus as cornerstone immunosuppressant in kidney transplantation 46
Cadaveric organ donors and malignancy. Our experience in Italy 45
Epidemiological study on the infections due to pathogenous microrganisms in an intensive care unit 45
Terapia con alpha Interferon nel trapianto d’organo: studio delle attività citotossiche. 45
TRATTAMENTO DELLE NEOPLASIE MALIGNE DEL RENE CON TROMBOSI CAVALE: DESCRIZIONE DI APPROCCIO CHIRURGICO ORIGINALE. 45
INFLUENCE OF TOTAL LYMPHOID IRRADIATION PLUS CYCLOSPORINE ON KIDNEY GRAFT OUTCOME IN HIGH-RISK PATIENTS 45
SOPRAVVIVENZA DOPO TRAPIANTO DI RENE DA DONATORE VIVENTE: ESPERIENZA DI UN SINGOLO CENTRO 44
Research for optimization in organ donation in a macro-area after federal reform of the Italian health system 44
Totale 6.640
Categoria #
all - tutte 30.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.011 0 0 0 0 0 0 262 240 185 166 108 50
2020/2021783 109 82 41 124 19 40 27 74 77 116 49 25
2021/20221.923 5 119 156 71 260 38 31 182 149 165 306 441
2022/20231.982 497 345 126 231 207 199 19 94 176 27 43 18
2023/2024924 69 89 21 104 56 134 37 65 7 121 110 111
2024/2025855 68 86 217 64 220 200 0 0 0 0 0 0
Totale 10.087